Jérôme de Sèze to Young Adult
This is a "connection" page, showing publications Jérôme de Sèze has written about Young Adult.
Connection Strength
0.103
-
Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders. Eur J Neurol. 2021 Oct; 28(10):3461-3466.
Score: 0.024
-
Outcomes and treatment management of a French cohort suffering from multiple sclerosis: A retrospective epidemiological study. Mult Scler Relat Disord. 2018 Oct; 25:276-281.
Score: 0.021
-
Relapsing optic neuritis: a multicentre study of 62 patients. Mult Scler. 2014 06; 20(7):848-53.
Score: 0.015
-
Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection. J Infect Dis. 2021 11 16; 224(9):1489-1499.
Score: 0.007
-
Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies. Diagn Microbiol Infect Dis. 2020 Dec; 98(4):115181.
Score: 0.006
-
Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study. Radiology. 2020 11; 297(2):E242-E251.
Score: 0.006
-
Multiple sclerosis with atypical MRI presentation: Results of a nationwide multicenter study in 57 consecutive cases. Mult Scler Relat Disord. 2019 Feb; 28:109-116.
Score: 0.005
-
Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study. Neurology. 2018 05 22; 90(21):e1858-e1869.
Score: 0.005
-
Air pollution by particulate matter PM10 may trigger multiple sclerosis relapses. Environ Res. 2017 07; 156:404-410.
Score: 0.005
-
Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis. PLoS One. 2017; 12(1):e0168834.
Score: 0.005
-
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis. N Engl J Med. 2017 01 19; 376(3):209-220.
Score: 0.005